IDiyas

For the Inventor, By the Inventor

Ludwigshafen, Germany

Harald Weifenbach

USPTO Granted Patents = 8

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:

goldMedal8 out of 10,754 
 
Basf Aktiengesellschaft
 patents

Years Active: 1982-1995

Loading Chart...
8 patents (USPTO):
1. 5414006 - Arylalkoxythiocoumarins, the preparation thereof and therapeutic (1995-05-09),
2. 5227392 - Alkoxycoumarins substituted by a heterocyclic radical, their preparation (1993-07-13),
3. 5100914 - Arylalkoxycoumarins (1992-03-31),
4. 5073563 - Alkoxycoumarins substituted by a heterocyclic radical, their preparation (1991-12-17),
5. 4877807 - 5-phenyl-1,2,3a,4,5,9b-hexahydro-3H-benz(e)indotes preparation and use (1989-10-31),
6. 4824862 - 3-phenyl-2-styrylpyrrolidines, preparation and use thereof (1989-04-25),
7. 4619929 - Phenylpiperazine derivatives of hetarylphenols and hetarylanilines, (1986-10-28),
8. 4335138 - Novel carbamates, their preparation, and pharmaceutical formulations (1982-06-15),

Title: **The Innovative Mind of Harald Weifenbach: A Leader in the Field of Arylalkoxythiocoumarins**

Introduction

Harald Weifenbach, a distinguished inventor based in Ludwigshafen, Germany, has made significant contributions to the realm of chemical innovations with a focus on Arylalkoxythiocoumarins. Over his career, he has been awarded eight patents, showcasing his expertise and innovative spirit in the field.

Latest Patents

Harald's latest patents involve complex compounds, particularly Arylalkoxythiocoumarins. These patents detail the preparation processes and therapeutic applications of these compounds, which are characterized by specific chemical formulas. The first patent centers on Arylalkoxythiocoumarins where R1 and R2 can be various configurations such as hydrogen, C1-C5 alkyl, trifluoromethyl, or other specified groups. Similarly, his other recent patent focuses on alkoxycoumarins substituted by heterocyclic radicals, offering a range of options for R1, R2, R3, and R4, thereby expanding the potential for these innovative compounds in therapeutic applications.

Career Highlights

Throughout his career, Harald has demonstrated a commitment to excellence in research and development. His role at BASF Aktiengesellschaft, a leading chemical company, has provided him with a dynamic platform to further his research and innovation. His patents reflect a deep understanding of chemistry and its applications in medicine and industry.

Collaborations

Collaboration plays a crucial role in innovation, and Harald has worked alongside notable colleagues such as Hans-Juergen Teschendorf and Beatrice Rendenbach-Mueller. These partnerships have fostered an environment of creativity and knowledge-sharing, leading to successful outcomes in their projects.

Conclusion

Harald Weifenbach exemplifies the spirit of innovation in the chemical sector. With eight patents to his name, his work on Arylalkoxythiocoumarins highlights his dedication and inventive capabilities. Through his career at BASF and collaborations with esteemed colleagues, he continues to contribute to advancements in the field, shaping the future of chemical applications in health and industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…